Sign in

CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
611547851
Phone
(858) 500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
Open-market buys, last 90 days
$1,239,000
in 1 filing
Open-market sales, last 90 days
$1,708,041
in 8 filings, $650K under 10b5-1 plans

Net −$469,041. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-24 Burrows Francis Chief Scientific Officer Option exercise +30,000 $6.15 $185K 63,053
2026-09-24 Burrows Francis Chief Scientific Officer Sale −20,726 $10.83 $225K 42,327
2026-09-24 Burrows Francis Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −30,000 0
2026-01-27 Burrows Francis Chief Scientific Officer Sale −1,311 $8.46 $11K 32,424
2026-01-02 Burrows Francis Chief Scientific Officer Grant or award · Option to purchase common stock +185,000 185,000
2025-12-18 Burrows Francis Chief Scientific Officer Option exercise +35,000 $4.80 $168K 57,461
2025-12-18 Burrows Francis Chief Scientific Officer Sale −23,726 $9.78 $232K 33,735
2025-12-18 Burrows Francis Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −35,000 0
2025-01-28 Burrows Francis Chief Scientific Officer Sale −846 $7.87 $7K 22,025
2025-01-28 Burrows Francis Chief Scientific Officer Sale −1,320 $7.87 $10K 20,705
2025-01-02 Burrows Francis Chief Scientific Officer Grant or award · Option to purchase common stock +185,000 185,000

Page 1 of 1 · 11 trades